Autopsy report · NCT03943134
Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity
Cause of deathFunding or business
“Axogen suspended market availability of the Avive® Soft Tissue Membrane effective June 1, 2021. This decision was not related to any safety concerns or product quality issues.”
Life of this trial
- Registered 5 months after it had already started.
- Ran for about 2 years 1 month before it stopped.
- 7 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Axogen Corporation
- Sponsor type
- Industry
- Conditions
- Acute Upper Extremity Trauma
- Interventions
- Minimally Processed Human Umbilical Cord Membrane; Standard Surgical Procedures
- Participants
- 7
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.